Farallon Capital Management LLC Avidity Biosciences, Inc. Transaction History
Farallon Capital Management LLC
- $21.4 Billion
- Q1 2024
A detailed history of Farallon Capital Management LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 606,061 shares of RNA stock, worth $16.3 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
606,061
Previous 606,061
-0.0%
Holding current value
$16.3 Million
Previous $15.5 Million
-0.0%
% of portfolio
0.07%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding RNA
# of Institutions
164Shares Held
71.6MCall Options Held
182KPut Options Held
55K-
Rtw Investments, LP New York, NY7.97MShares$214 Million3.26% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.43MShares$200 Million0.02% of portfolio
-
Black Rock Inc. New York, NY6.17MShares$166 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.83MShares$156 Million1.79% of portfolio
-
Cowen And Company, LLC5.63MShares$151 Million4.83% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.4B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...